ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
-19.11%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
–
AUM
$231M
AUM Growth
+$231M
Cap. Flow
-$16.2M
Cap. Flow %
-7.01%
Top 10 Hldgs %
97.81%
Holding
16
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

1
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
$15.2M
2
SPRB
Spruce Biosciences, Inc. Common Stock
SPRB
$948K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$9.89B
$154M 66.52% 6,068,125 – –
SNDX icon
2
Syndax Pharmaceuticals
SNDX
$1.41B
$21M 9.11% 1,025,000 – –
VRNA
3
Verona Pharma
VRNA
$9.16B
$16.1M 6.98% 1,115,352 – –
ELEV
4
DELISTED
Elevation Oncology
ELEV
$7.65M 3.31% 2,834,910 – –
NUVB icon
5
Nuvation Bio
NUVB
$1.02B
$7.42M 3.21% 2,541,009 – –
CMPS
6
Compass Pathways
CMPS
$424M
$5.83M 2.52% 964,500 – –
GLUE icon
7
Monte Rosa Therapeutics
GLUE
$296M
$5.51M 2.38% 1,472,331 – –
BMEA icon
8
Biomea Fusion
BMEA
$116M
$3.59M 1.56% 798,757 – –
PSTX
9
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$3.05M 1.32% 1,043,267 – –
CALC icon
10
CalciMedica
CALC
$37.7M
$2.06M 0.89% 521,114 – –
MRKR icon
11
Marker Therapeutics
MRKR
$12M
$1.71M 0.74% 314,286 – –
TECX
12
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$1.39M 0.6% 84,148 -925,631 -92% -$15.2M
OKUR
13
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$1.34M 0.58% 886,075 – –
ACRS icon
14
Aclaris Therapeutics
ACRS
$209M
$478K 0.21% 434,455 – –
VIRX
15
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$157K 0.07% 288,571 – –
SPRB
16
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
– – -1,205,511 Closed -$948K